Daniel R. - $10,500,000.00
Lyrica
Lyrica Highlights
- Prescribed to treat pain associated with epilepsy, diabetic neuropathy, and fibromyalgia.
- In 2009, manufacturer pled guilty to misbranding Lyrica “with the intent to defraud or mislead.”
- $2.3 billion dollars: Pfizer paid in settlement after its criminal prosecution for fraud and the illegal promotion of Lyrica.
About Lyrica
In 2004, the anticonvulsant Lyrica (also known as pregabalin), from Pfizer, Inc., was approved by the FDA for the treatment of epilepsy and diabetic neuropathic pain. In 2006, Lyrica was further approved to treat the pain associated with fibromyalgia and spinal cord injuries. Until 2008, it was the only approved treatment for fibromyalgia and was heavily marketed for the treatment of that disorder. However, Pfizer failed to ensure that it adequately disclosed the risks associated with the drug, including an increased risk of suicide.
If you or a loved one has attempted or committed suicide, or has experienced other side effects from taking Lyrica, you may be entitled to a cash settlement. Please complete the form and one of our attorneys will contact you or call 1-800-LAW-FIRM now.
In 2008, the FDA issued a warning that Lyrica, Neurontin and other anticonvulsants could cause increase a patient’s risk of suicidal thoughts and behaviors. An FDA study of 11 anticonvulsants/antiepileptics found that people taking the medications had double the risk of suicidal thoughts and behaviors compared to those taking a placebo.
In 2009, a division of Pfizer pled guilty to misbranding Lyrica “with the intent to defraud or mislead.” The division subsequently entered into a corporate integrity agreement and settled the case for $2.3 billion dollars.
Conditions Caused By Lyrica
- Suicide
- Hypotension and hypertension
- Pancreatitis
- Dysphagia
- Rhabdomyolysis
Side Effects & Symptoms
- Suicidal thoughts, ideations, or depression
- Hypotension: lightheadedness, dizziness, fainting, seizures
- Hypertension: severe headaches, insomnia, confusion, nausea, vomiting
- Dysphagia: difficulty swallowing, coughing, controlling food in the mouth
- Rhabdomyolysis: pain, tenderness, weakness, and swelling of affected muscles
- Pancreatitis: severe upper abdominal pain, nausea, vomiting
Warnings & Recalls
In 2008, the FDA issued a warning regarding an increased risk of suicide among those taking Lyrica.
Cases, Settlements, & Verdicts
$2.3 billion dollars: Pfizer paid in settlement after its criminal prosecution for fraud and the illegal promotion of Lyrica.
